The use of cardiovascular magnetic resonance in acute myocardial infarction.
Acute myocardial infarction (MI) results in reversible and irreversible injury to the myocardium, including stunning, edema, myocyte necrosis, and microvascular obstruction. Because of its unique tissue characterization capabilities, cardiovascular magnetic resonance provides a reliable means of visualizing and quantifying the extent of these injuries. Such characterization is readily achieved through a comprehensive examination including function, first-pass perfusion, T2 (edema), and late enhancement imaging sequences. This helps to predict the prognosis, assess the success of reperfusion, detect acute phase complications, localize the area of the acute event, and confirm the diagnosis in clinical scenarios with clinical presentations similar to that of acute MI. Finally, one emerging application is the role cardiovascular magnetic resonance (CMR) may play in detecting some infarcts very early on in their evolution. This article covers the established and emerging clinical applications of CMR in the settings of reperfused and nonreperfused infarcts and in acute myocardial ischemia, the step immediately preceding actual irreversible injury.
Abdel-Aty
Hassan
H
Cardio Imaging Center Berlin, Paretzer Strasse 12, Berlin-Wilmersdorf 10713, Germany. abdel-aty@cardiomrt.de
Tillmanns
Christoph
C
D004489:Edema, Cardiac / Q000175:diagnosis / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000295:instrumentation*; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000473:pathology; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000473:pathology; D015425:Myocardial Reperfusion; D009206:Myocardium; D011379:Prognosis; D011856:Radiographic Image Enhancement; D018570:Risk Assessment; D015646:Ventriculography, First-Pass